Georgia Lung Cancer Newswire

Get by Email • RSS

No articles found

07 days 11:23:37

Featured Releases

Got News to Share? · Submit · See All

Published on March 31, 2025 - 12:00 GMT

Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib

LaunXP receives exclusive development and commercialization rights for vebreltinib in combination with an EGFR inhibitor in Asia (excluding mainland China, Hong Kong and Macau) for the treatment of non-small cell lung cancer (“NSCLC”) Apollomics to receive …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 27, 2025 - 20:15 GMT

Nanobiotix annonce les premières données issues de la partie escalade de dose completée d’une étude de Phase 1 évaluant ...

Les données montrent un profil de sécurité favorable et confirment la faisabilité de l’injection chez 12 patients atteints d’un cancer du poumon (CPNPC) localement avancé éligibles à une ré-irradiation et pour lesquels les lignes de traitement antérieures …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on March 27, 2025 - 12:30 GMT

Global Radiotherapy Market Expected to Reach $9.62 Billion By 2030 Realizing Growth Due to Technological Advancements

PALM BEACH, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Industry experts see the global radiotherapy market continuing to grow in the years to come. A recent report from MarketsAndMarkets said that the global radiotherapy …

Distribution channels: Technology ...
Published on March 27, 2025 - 11:00 GMT

Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates

Revenue in 2024 increased 342% year-over-year to US$134.3 million (RMB980.7 million), attributable in part to Takeda’s option payment and strong sales growth of olverembatinib Sales of olverembatinib in China in 2024 increased 52% year-over-year to US$33.0 …

Distribution channels:

Got news to share? Submit it now.

Load more lung cancer news or search news using your own keywords. There are 798,776,404 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Lung Cancer News by Country

Lung Cancer News by U.S. State

Lung Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on March 31, 2025 - 14:00 GMT

Elder Law: Protecting the Rights of Seniors

RENO, NV, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- As the US population ages, the significance of elder law continues to grow, addressing a variety of legal issues that affect older adult citizens. This vital field encompasses areas …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 13:00 GMT

Global Digital Media Production Market Outlook 2025-2034: Growth Drivers, Share, And Trends

The Business Research Company's Digital Media Production Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 31, 2025 /⁨EINPresswire.com⁩/ -- Recent years have witnessed …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 13:00 GMT

OpenDNA and Mayo Clinic Present AI-Powered Heart Disease Risk Prediction Model at the American College of Cardiology

OpenDNA and Mayo Clinic Presents AI-Powered Heart Disease Risk Prediction Model at the American College of Cardiology Conference 2025 in Chicago GAITHERSBURG, MD, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- This week, OpenDNA and Mayo …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 12:12 GMT

allGeo, a Service by Abaqus Inc., Enhances Its End-to-End Field Workflow Automation Capabilities

allGeo enhances field service automation with scheduling, advanced time & jobs tracking, ERP & payroll integration, and compliance reporting. PALO ALTO, CA, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- Abaqus Inc., a leader in …

Distribution channels: Building & Construction Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 10:00 GMT

New Resources for Psychedelic Therapy: Matt Zemon and Ken Weingardt Unveil The Beginner’s Guide to Psychedelics

Empowering Individuals and Professionals with Practical Tools for Psychedelic Preparation, Integration, and Healing. CHAPEL HILL, NC, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- Matt Zemon, MSc, educator and author in psychedelic …

Distribution channels: Book Publishing Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 13:30 GMT

Trethera Treats a Late Stage, Heavily Pretreated Amyotrophic Lateral Sclerosis (ALS) Patient with TRE 515

LOS ANGELES, March 31, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to targeting cancer and autoimmune diseases through first-in-class drugs, announced clinical results from treating a …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on March 31, 2025 - 13:00 GMT

Muscular Dystrophy Association and Burn Boot Camp Team Up for the 9th Annual ‘Be Their Muscle’ Philanthropic Event

CHARLOTTE, N.C., March 31, 2025 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) has teamed up with Burn Boot Camp, a leading boutique fitness franchise, for the 9th annual national 'Be Their Muscle' philanthropic event. Throughout April, …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on March 31, 2025 - 12:48 GMT

Prime Biome Reviews [DOCTOR INVESTIGATION TRUTH]: The Revolutionary Supplement Transforming Gut Health & Wellness

ORLANDO, Fla., March 31, 2025 (GLOBE NEWSWIRE) -- The pioneering solution Prime Biome provides USA residents with a way to recover their microbiome equilibrium and boost their digestive abilities and help their immune systems work more effectively. Prime …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on March 31, 2025 - 12:30 GMT

Safety Shot Provides Business Update from CEO Jarrett Boon

SCOTTSDALE, Ariz., March 31, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”), a wellness and dietary supplement company, today provides a business update from CEO Jarrett Boon. To our valued stakeholders, As we …

Distribution channels:
Published on March 31, 2025 - 12:00 GMT

Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference

WEST CHESTER, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced …

Distribution channels:
Published on March 31, 2025 - 12:00 GMT

BetterLife Pharma Appoints New Director

VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce it has appointed Dr. Steven Sangha …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on March 31, 2025 - 12:00 GMT

KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

-- Randomized 87 patients to date in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED) -- -- Continuing enrollment into 2Q25; currently targeting topline data in 3Q25 -- -- Raised $10.75 million in private placement financing …

Distribution channels:
Published on March 31, 2025 - 12:00 GMT

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

GARDEN CITY, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on March 31, 2025 - 12:00 GMT

Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-...

DUBLIN and BRIDGEWATER, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted key data presentations at ACC.25 showcasing the mechanistic activity of eicosapentaenoic acid (EPA) on lipoprotein(a) [Lp(a)]-enriched …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on March 31, 2025 - 12:00 GMT

Synergy CHC Reports its Eighth Consecutive Quarter of Profitability and its Fourth Quarter and Full Year 2024 Financial ...

WESTBROOK, Maine, March 31, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, is announcing its financial results for the three and twelve months ended …

Distribution channels:
Published on March 31, 2025 - 11:30 GMT

Palvella Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update

Upon close of merger and $78.9mm concurrent private placement from a syndicate of leading healthcare-dedicated investors, completed transformation to a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage pipeline and a …

Distribution channels:
Published on March 31, 2025 - 11:00 GMT

BioStem Announces Notice of Allowance for Two U.S. Patent Applications

POMPANO BEACH, Fla., March 31, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...
Published on March 31, 2025 - 11:00 GMT

Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related ...

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that the National Medical Products Administration (NMPA) of the People …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on March 31, 2025 - 11:00 GMT

Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study

-- At All Doses Evaluated, VAX-24 Was Well-Tolerated and Demonstrated a Safety and Tolerability Profile Similar to Prevnar 20® (PCV20) -- -- At All Doses Evaluated, VAX-24 Elicited Substantial Immune Responses Following Primary Three-Dose Immunization …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on March 31, 2025 - 11:00 GMT

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Over $20M raised in Q1 with nearly $15M cash on hand No debt, no preferred equity, and no warrants with strike prices near the current market Nasdaq compliant: fully meets bid price and shareholder equity requirements Pivotal CLARITY trial fully funded …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...